Log in
Register
Subscribe
Contact Us
ISSN 1933-0863 (PRINT) ISSN 1933-0871 (ONLINE)
Menu
Home
About the Journal
About Journal
Aim & Scope
Editorial Board
Advertising
Contact
Contents
Contents
Latest Issue
Archives
Guidelinest
Guidelines
Submission Guidelines
Peer Review
Policies
CopyRights
Permissions
Free Access
Ethics
share
Table of Contents
2023 OCT- Q3 ISSUE
FREE ACCESS:
Cytoreductive Nephrectomy for met-RCC – Current Concepts and Contentions in the Era of ICIs
FREE ACCESS:
Current Perspective on the Impact of Endogenous Retroviruses in ccRCC
FREE ACCESS:
An Opportunity to Study Mechanisms of Palliative Care by Integrating into Management of Treatment of RCC
FREE ACCESS:
HIF Pathway Inhibition hold much promise and Point Toward an expanding RCC Armamentarium- Editorial Memo
FREE ACCESS:
Journal Club
FREE ACCESS:
KCJ Medical Intelligence
2023 MARCH - Q2 ISSUE
FREE ACCESS:
Ex-Vivo Partial Nephrectomy in a Solitary Kidney
FREE ACCESS:
Robotic-assisted cytoreductive partial nephrectomy for msRCC following IO
FREE ACCESS:
Kidney Cancer Updates from the 2023 ASCO Meeting in Chicago
FREE ACCESS:
ASCO 2023 - Recommended Abstracts
FREE ACCESS:
Journal Club
FREE ACCESS:
ASCO 2023 Kidney Cancer Roundup - Editor's Memo
2022 MARCH - Q1 ISSUE
FREE ACCESS:
Recent Advances in BEMPEG (NKTR-214) plus NIVOLUMAB Combination Strategies in Advanced Renal Cell Carcinoma
FREE ACCESS:
The Latinx Disparity in Surgery for Kidney Cancer: Data from The South Texas Region
FREE ACCESS:
Moving Beyond BMI – Developments in Body Composition and Muscle Measurement in RCC
FREE ACCESS:
Kidney Cancer Research Highlights from ASCO GU 2022 Meeting
FREE ACCESS:
ASCO GU22 – Kidney Cancer Highlights
FREE ACCESS:
20th Anniversary of Kidney Cancer Journal - Editor's Memo
DECEMBER 2021 ISSUE
FREE ACCESS:
Radiological Correlates of pT3a Kidney Cancer: Importance of Irregular Tumor Sinus Border
FREE ACCESS:
COMMENTARY: How Can We Predict pT3a Kidney Cancer and What Does It Mean?
FREE ACCESS:
A Tribute to Dr. Christopher G. Wood, MD
FREE ACCESS:
IKCS 2021- TOP ABSTRACTS
FREE ACCESS:
IKCS 2021 meeting coverage. Marc Matrana, MD.
FREE ACCESS:
The COVID-19 conundrum, vaccines, and cancer care. Robert A. Figlin, MD
FREE ACCESS:
KCJ Journal Club
JUNE 2021 ISSUE
FREE ACCESS:
Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial
FREE ACCESS:
The Pathway of Belzutifan, from clinical trials to clinical practice:
FREE ACCESS:
The Current and Evolving Therapeutic Paradigm in the Management of Metastatic Renal Cell Carcinoma
FREE ACCESS:
EXPERT PERSPECTIVES - Nicholas J. Vogelzang, MD, FASCO, FACP
FREE ACCESS:
EDITOR'S MEMO
FREE ACCESS:
KCJ Journal Club
FREE ACCESS:
MEDICAL INTELLIGENCE
JUNE 2021 ISSUE
FREE ACCESS:
Resource-efficient pooled sequencing expands translational impact in solid tumors
FREE ACCESS:
ROUNDTABLE: Changes, Challenges and Opportunities in Cancer Care During the COVID-19 Era and Beyond
FREE ACCESS:
Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle
FREE ACCESS:
Editor's Memo - Robert A. Figlin, MD
FREE ACCESS:
KCJ Journal Club
FREE ACCESS:
Newsworthy, late-breaking information from Web-based sources, professional societies, and government agencies
ASCO SUPPLEMENT - JUNE 2021
FREE ACCESS:
RECOMMENDED ABSTRACTS IN KIDNEY CANCER
FREE ACCESS:
Practice Changing Results in RCC come from ASCO21
FREE ACCESS:
ASCO21 – Kidney Cancer Highlights
FREE ACCESS:
ASCO21 – Key Updates for Kidney Cancer Patients
FREE ACCESS:
Novel Strategies in Locally Advanced Kidney Cancer – Highlights from KEYNOTE-564
MARCH 2021 ISSUE
FREE ACCESS:
ROUNDTABLE: TKIs Beyond Second-Line Therapy: New Perspectives in Renal Cell Carcinoma Therapeutics
FREE ACCESS:
Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS:
It’s Clear as Day: HIF Signaling is Driving Force of the Clear Cell Morphology
FREE ACCESS:
Editor's Memo - Robert A. Figlin, MD
FREE ACCESS:
Journal Club
Newsworthy, late-breaking information from Web-based sources, professional societies, and government agencies
FREE ACCESS:
Editor's Memo - Robert A. Figlin, MD (Recent)
DECEMBER 2020 ISSUE
FREE ACCESS:
Impact of Mycobacterial Infections on Outcomes of Patients with Metastatic Renal Cell Carcinoma
FREE ACCESS:
Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS:
HIF-inhibitors in Renal Cell Carcinomas: A Review of Current Trials
FREE ACCESS:
Academic Mentorship: Choosing the Right Research Mentor(s)
KCJ EDITOR’S MEMO
KCJ MEDICAL INTELLIGENCE
KCJ JOURNAL CLUB - ESSENTIAL PEER-REVIEWED READING IN KIDNEY CANCER (FREE ACCESS available soon)
Download PDF
KCJ
Vol 19, Issue 2
June 2021
Table of contents
Article Tools
Stay Connected to KCJ
Facebook
Twitter
×
Subscription Sign Up
Sign Up
Feel free to choose as many as you like.
Newsletter
Print Copy of KCJ
electronic KCJ
Terms of Service
*
Agree to the terms. We (KCJ) will not, in any circumstances, share your personal information with other individuals or organizations without your permission, including public organizations, corporations or individuals, except when applicable by law. We do not sell, communicate or divulge your information to any mailing lists.